Daratumumab Monotherapy for Relapsed or Refractory Multiple Myeloma: Results of an Early Access Treatment Protocol in Europe and Russia

Cook, G; Corso, A; Streetly, M; Mendeleeva, LP; Ptushkin, VV; Chan, E; Ukropec, J; Iraqi, W; Al-Akabawi, A; Pei, HL; Gaudig, M; Petrucci, MT; Alegre, A; Mateos, MV

Cook, G (corresponding author), Leeds Teaching Hosp NHS Trust, Leeds Canc Ctr, Leeds, W Yorkshire, England.; Cook, G (corresponding author), Univ Leeds, Leeds, W Yorkshire, England.

ONCOLOGY AND THERAPY, ; ():

Abstract

Introduction: Daratumumab is a human IgG kappa monoclonal antibody targeting CD38. Despite the demonstrated benefit of daratumumab in multiple myeloma......

Full Text Link